KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $9.0 million.

  • Guardant Health's Depreciation and Depletion fell 1089.11% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year decrease of 496.28%. This contributed to the annual value of $40.1 million for FY2024, which is 25.0% up from last year.
  • As of Q3 2025, Guardant Health's Depreciation and Depletion stood at $9.0 million, which was down 1089.11% from $9.6 million recorded in Q2 2025.
  • Guardant Health's Depreciation and Depletion's 5-year high stood at $10.3 million during Q3 2023, with a 5-year trough of $4.5 million in Q1 2021.
  • In the last 5 years, Guardant Health's Depreciation and Depletion had a median value of $9.6 million in 2023 and averaged $8.5 million.
  • As far as peak fluctuations go, Guardant Health's Depreciation and Depletion soared by 8200.0% in 2022, and later tumbled by 1089.11% in 2025.
  • Quarter analysis of 5 years shows Guardant Health's Depreciation and Depletion stood at $5.6 million in 2021, then skyrocketed by 69.64% to $9.5 million in 2022, then grew by 6.32% to $10.1 million in 2023, then fell by 1.98% to $9.9 million in 2024, then decreased by 9.09% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $9.6 million for Q2 2025, and $9.8 million during Q1 2025.